Related Experiment Video

Updated: Apr 18, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.6K

[Stenting vs. surgery for symptomatic carotid stenosis]

David Calvet1, Jean-Louis Mas1

  • 1Centre hospitalier Sainte-Anne, université Paris-Descartes, service de neurologie, centre de psychiatrie et neurosciences, Inserm UMR 894, 75014 Paris, France.

Presse Medicale (Paris, France : 1983)
|January 18, 2015
PubMed

Insights

Carotid stenting carries a higher stroke risk than surgery, particularly for patients over 70. Both interventions effectively prevent future strokes after the procedure.

Area of Science:

  • Neurology
  • Vascular Surgery
  • Interventional Cardiology

Context:

  • Severe symptomatic carotid stenosis presents a significant stroke risk.
  • Treatment decisions involve balancing procedural risks with long-term efficacy.
  • Patient age and comorbidities influence intervention choice.

Purpose:

  • To compare the periprocedural stroke risk between carotid stenting and surgery.
  • To evaluate the long-term effectiveness of both interventions in stroke prevention.
  • To provide guidance on selecting the optimal revascularization strategy for carotid stenosis.

Summary:

  • Carotid stenting is linked to a higher periprocedural stroke risk, especially in patients over 70.
  • Stroke risk appears similar between stenting and surgery in patients under 70.
  • Both methods offer comparable long-term stroke prevention after the acute procedural phase.
  • Surgery is the preferred treatment for severe symptomatic carotid stenosis.
  • Stenting is a viable option for patients with surgical contraindications or high comorbidity-related risks.
  • Timely revascularization, within two weeks of a TIA or moderate stroke, is recommended.

Impact:

  • Informs clinical decision-making for carotid stenosis management.
  • Highlights the importance of patient-specific risk stratification for intervention selection.
  • Supports a multidisciplinary approach to optimize patient outcomes in cerebrovascular disease.

More Related Videos

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers12:30

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers

Published on: August 12, 2014

10.2K
A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis09:36

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

859

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
465
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
488
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
437
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
626
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
459